Bibliography | CPRD

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,500 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 July 2020) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

CPRD bibliography

CPRD bibliography

(PDF, 3MB, 206 pages)

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.

Export 34 results:

Filters: Author is Kaye, J. A. [Clear All Filters]

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A

J. A. Kaye, Myers, M. W., and Jick, H., “Acetaminophen and the risk of renal and bladder cancer in the general practice research database”, Epidemiology, vol. 12, pp. 690-4, 2001.

J. A. Kaye and Jick, H., “Antibiotics and the risk of breast cancer”, Epidemiology, vol. 16, pp. 688-90, 2005.

H. Jick, Kaye, J. A., and Jick, S. S., “Antidepressants and the risk of suicidal behaviors”, Jama, vol. 292, pp. 338-43, 2004.

H. Jick and Kaye, J. A., “Autism and DPT vaccination in the United Kingdom”, N Engl J Med, vol. 350, pp. 2722-3, 2004.

C

J. A. Kaye, Margulis, A. V., Fortuny, J., McQuay, L. J., Plana, E., Bartsch, J. L., Bui, C. L., Perez-Gutthann, S., and Arana, A., “Cancer Incidence after Initiation of Antimuscarinic Medications for Overactive Bladder in the United Kingdom: Evidence for Protopathic Bias”, Pharmacotherapy, vol. 37, pp. 673-683, 2017.

C. Black, Kaye, J. A., and Jick, H., “Cesarean delivery in the United Kingdom: time trends in the general practice research database”, Obstet Gynecol, vol. 106, pp. 151-5, 2005.

J. A. Kaye, Bradbury, B. D., and Jick, H., “Changes in antipsychotic drug prescribing by general practitioners in the United Kingdom from 1991 to 2000: a population-based observational study”, Br J Clin Pharmacol, vol. 56, pp. 569-75, 2003.

C. Black, Kaye, J. A., and Jick, H., “Clinical risk factors for venous thromboembolus in users of the combined oral contraceptive pill”, Br J Clin Pharmacol, vol. 53, pp. 637-40, 2002.

J. Castellsague, Kuiper, J. G., Pottegard, A., I. Berglind, A., Dedman, D., Gutierrez, L., Calingaert, B., van Herk-Sukel, M. P., Hallas, J., Sundstrom, A., Gallagher, A. M., Kaye, J. A., Pardo, C., Rothman, K. J., and Perez-Gutthann, S., “A cohort study on the risk of lymphoma and skin cancer in users of topical tacrolimus, pimecrolimus, and corticosteroids (Joint European Longitudinal Lymphoma and Skin Cancer Evaluation - JOELLE study)”, Clin Epidemiol, vol. 10, pp. 299-310, 2018.

D

S. S. Jick, Kaye, J. A., and Jick, H., “Diclofenac and acute myocardial infarction in patients with no major risk factors”, Br J Clin Pharmacol, vol. 64, pp. 662-7, 2007.

E

H. Jick and Kaye, J. A., “Epidemiology and possible causes of autism”, Pharmacotherapy, vol. 23, pp. 1524-30, 2003.

W. M. Schoonen, Kucera, G., Coalson, J., Li, L., Rutstein, M., Mowat, F., Fryzek, J., and Kaye, J. A., “Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database”, Br J Haematol, vol. 145, pp. 235-44, 2009.

J. A. Kaye and Jick, H., “Epidemiology of lower limb fractures in general practice in the United Kingdom”, Inj Prev, vol. 10, pp. 368-74, 2004.

M. Yong, Schoonen, W. M., Li, L., Kanas, G., Coalson, J., Mowat, F., Fryzek, J., and Kaye, J. A., “Epidemiology of paediatric immune thrombocytopenia in the General Practice Research Database”, Br J Haematol, vol. 149, pp. 855-64, 2010.

I

H. Jick, Kaye, J. A., and Black, C., “Incidence and prevalence of drug-treated attention deficit disorder among boys in the UK”, Br J Gen Pract, vol. 54, pp. 345-7, 2004.

J. A. Kaye, Derby, L. E., M. Melero-Montes, delMar, Quinn, M., and Jick, H., “The incidence of breast cancer in the General Practice Research Database compared with national cancer registration data”, Br J Cancer, vol. 83, pp. 1556-8, 2000.

J. A. Kaye and Jick, H., “Incidence of erectile dysfunction and characteristics of patients before and after the introduction of sildenafil in the United Kingdom: cross sectional study with comparison patients”, Bmj, vol. 326, pp. 424-5, 2003.

M

C. Black, Kaye, J. A., and Jick, H., “MMR vaccine and idiopathic thrombocytopaenic purpura”, Br J Clin Pharmacol, vol. 55, pp. 107-11, 2003.

J. A. Kaye, M. Melero-Montes, delMar, and Jick, H., “Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis”, Bmj, vol. 322, pp. 460-3, 2001.

N

H. Jick, Kaye, J. A., Russmann, S., and Jick, S. S., “Nonsteroidal antiinflammatory drugs and acute myocardial infarction in patients with no major risk factors”, Pharmacotherapy, vol. 26, pp. 1379-87, 2006.

O

B. D. Bradbury, Wilk, J. B., and Kaye, J. A., “Obesity and the risk of prostate cancer (United States)”, Cancer Causes Control, vol. 16, pp. 637-41, 2005.

P

J. A. Kaye and Jick, H., “Proton pump inhibitor use and risk of hip fractures in patients without major risk factors”, Pharmacotherapy, vol. 28, pp. 951-9, 2008.

R

C. Black, Kaye, J. A., and Jick, H., “Relation of childhood gastrointestinal disorders to autism: nested case-control study using data from the UK General Practice Research Database”, Bmj, vol. 325, pp. 419-21, 2002.

S. Russmann, Kaye, J. A., Jick, S. S., and Jick, H., “Risk of cholestatic liver disease associated with flucloxacillin and flucloxacillin prescribing habits in the UK: cohort study using data from the UK General Practice Research Database”, Br J Clin Pharmacol, vol. 60, pp. 76-82, 2005.

S. S. Jick, Hagberg, K. W., Kaye, J. A., and Jick, H., “The risk of unintended pregnancies in users of the contraceptive patch compared to users of oral contraceptives in the UK General Practice Research Database”, Contraception, vol. 80, pp. 142-51, 2009.

H. Jick, Kaye, J. A., Vasilakis-Scaramozza, C., and Jick, S. S., “Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with levonorgestrel before and after 1995: cohort and case-control analysis”, Bmj, vol. 321, pp. 1190-5, 2000.

S

J. A. Kaye and Jick, H., “Statin use and cancer risk in the General Practice Research Database”, Br J Cancer, vol. 90, pp. 635-7, 2004.

J. A. Kaye, Meier, C. R., Walker, A. M., and Jick, H., “Statin use, hyperlipidaemia, and the risk of breast cancer”, Br J Cancer, vol. 86, pp. 1436-9, 2002.

T

B. D. Bradbury, Lash, T. L., Kaye, J. A., and Jick, S. S., “Tamoxifen and cataracts: a null association”, Breast Cancer Res Treat, vol. 87, pp. 189-96, 2004.

B. D. Bradbury, Lash, T. L., Kaye, J. A., and Jick, S. S., “Tamoxifen-treated breast carcinoma patients and the risk of acute myocardial infarction and newly-diagnosed angina”, Cancer, vol. 103, pp. 1114-21, 2005.

V

A. V. Margulis, Fortuny, J., Kaye, J. A., Calingaert, B., Reynolds, M., Plana, E., McQuay, L. J., Atsma, W. J., Franks, B., de Vogel, S., Perez-Gutthann, S., and Arana, A., “Validation of Cancer Cases Using Primary Care, Cancer Registry, and Hospitalization Data in the United Kingdom”, Epidemiology, vol. 29, pp. 308-313, 2018.

S. S. Jick, Kaye, J. A., Vasilakis-Scaramozza, C., Rodriguez, L. A. Garcia, Ruigomez, A., Meier, C. R., Schlienger, R. G., Black, C., and Jick, H., “Validity of the general practice research database”, Pharmacotherapy, vol. 23, pp. 686-9, 2003.

A. V. Margulis, Fortuny, J., Kaye, J. A., Calingaert, B., Reynolds, M., Plana, E., McQuay, L. J., Atsma, W. J., Franks, B., de Vogel, S., Perez-Gutthann, S., and Arana, A., “Value of Free-text Comments for Validating Cancer Cases Using Primary-care Data in the United Kingdom”, Epidemiology, vol. 29, pp. e41-e42, 2018.

[Page last reviewed 6 July 2020]